Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 579,006 |
|
|||||
| News | - | ||||||
| Day High | 1.29 | Low High |
|||||
| Day Low | 1.09 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Organovo Holdings Inc | ONVO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.12 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.10 | 1.09 | 1.29 | 1.15 | 1.12 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,965 | 579,006 | $ 1.23 | $ 709,346 | - | 0.8911 - 2.23 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:47:26 | 1 | $ 1.17 | USD |
Organovo Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.55M | 10.04M | - | 370k | -17.26M | -1.72 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Organovo News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.02 | 1.74 | 1.00 | 1.34 | 11,178,323 | 0.10 | 9.80% |
| 1 Month | 1.04 | 1.74 | 0.99 | 1.33 | 3,017,487 | 0.08 | 7.69% |
| 3 Months | 1.02 | 1.74 | 0.8911 | 1.31 | 1,063,401 | 0.10 | 9.80% |
| 6 Months | 1.25 | 2.05 | 0.8911 | 1.31 | 608,286 | -0.13 | -10.40% |
| 1 Year | 2.19 | 2.23 | 0.8911 | 1.32 | 319,916 | -1.07 | -48.86% |
| 3 Years | 8.34 | 11.25 | 0.8911 | 2.83 | 168,446 | -7.22 | -86.57% |
| 5 Years | 1.00 | 23.92 | 0.1933 | 1.94 | 447,083 | 0.12 | 12.00% |
Organovo Description
| Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels. |
